We are soooo excited to put this out today; Please join us for our first social gathering on Wednesday 16th March 2022 at 8pm at The Canal House in Birmingham, kindly sponsored by Histocyte Register here https://t.co/AAPDZFcrzx
@TheIHCNetwork Is a new account aimed to help support, encourage, inspire, educate and motivate the immunohistochemistry scientific community. If you are interested in joining the network please get in touch! #IHC
We have joined the @Diaceutics DXRX network allowing a more targeted approach to improving quality of the tests histopathology labs perform. This is of particular importance to new novel drugs and the assays they require. Exciting times! https://t.co/bJ8fFlLJzo
Looking for a reliable and sustainable ALK-Lymphoma control? HistoCyte offers an ALK-Lymphoma (NPM-ALK) Analyte Control in cell line. Learn more today!
https://t.co/N5IODzOICN
During this period of social distancing we have taken measures to protect both our staff and our ability to maintain supply of products to our partners and customers. Stay safe folks. https://t.co/ulZjSeeNaJ
Looking forward to this meeting in June! Colin Tristram and Ian Milton from HistoCyte will be there. Will also hopefully presenting in the industry spot light session. We shall see! @IHC_NordiQC
It was great to have @HanbyAndrew Prof. Andy Hanby visit us yesterday to review some of the work we’ve done and look at our HER2 cells. Even better to think when he last visited there were half as many of us in a quarter of space we now have. #nicenewlabs!
HistoCyte are pleased to announce our Director and Co-founder Colin Tristram is speaking at the OLV Ziekenhuis Aalst-Asse-Ninove Pathology Symposium in Aalst, Netherlands next month.
Just launched our new Progesterone Receptor Analyte ControlDR, part of our Dynamic Range of products to sit alongside ER and HER2 https://t.co/fX754Txvk0